Henry Siegfried

DNP Doctor of Nursing Practice,  Cleveland Clinic 

Location: Africa

Consulting Services

Data Science-Bioinformatics Sales and Marketing Case Consulting Research Consulting

Areas Of Interest

Polycyclic Aromatic Hydrocarbons Aortitides, Giant Cell CDP Diglyceride Serine O-Phosphatidyltransferase TP-49 Anti-MuSK Myasthenia Gravis Lodgings, Patient-Family Mucus Protease Inhibitor Hypofractionation, Radiation Dose Hyaluronan Receptors Ebola Virus Technicians, Emergency Medicine Benedict Syndrome Infection, Cyclospora Cavovarus Foot Deformity Health Visitors Sorting, RNA Poly(rU) Encephalitis Viruses, St. Louis Urinary Bladder, Underactive Brosimum Receptors, V1 Travels, Sea Hamster, Golden Reticuloendothelioses, Systemic Aleukemic Central Core Disease Melatonin Receptors, Hematopoietic Growth Factors Demyelinating Autoimmune Diseases, CNS Laser Neurectomy

Professional Narrative

Dr. Henry Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Mayo Clinic 1987
Director Medicine, Amgen 1988

Education

Doctor of medicine, Baylor College 2014
Master of Science in physician assistant, Weill Medical College 1995

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :